ALABAMA RCT
Cross-source consensus on ALABAMA RCT from 1 sources and 5 claims.
1 sources · 5 claims
Where it comes from
Other
Other
Highlighted claims
- The PAAP and usual-care arms had 401 and 410 participants respectively. — The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis
- The economic evaluation used data from the ALABAMA randomized controlled trial. — The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis
- The ALABAMA trial enrolled adults with recorded penicillin allergy labels and recent antibiotic prescriptions. — The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis
- COVID-19 disruptions caused the ALABAMA trial to stop before reaching its planned sample size. — The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis
- Individual-level data came from linked primary care records, hospital records, and mortality data. — The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis